{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:03:01Z","timestamp":1793138581497,"version":"4.5.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232870","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T17:38:17Z","timestamp":1592501897000},"page":"e0232870","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-7155","authenticated-orcid":true,"given":"Nathalie","family":"Goemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Van den Hauwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sajeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Dieye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intekhab","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Collaborative Trajectory Analysis Project (cTAP)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"3","key":"pone.0232870.ref001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"JR Mendell","year":"2012","journal-title":"Ann Neurol"},{"issue":"10","key":"pone.0232870.ref002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"SJ Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"pone.0232870.ref003","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199681488.001.0001","volume-title":"Duchenne muscular dystrophy","author":"AE Emery","year":"2015"},{"key":"pone.0232870.ref004","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2147\/NDT.S93873","article-title":"Current and emerging treatment strategies for Duchenne muscular dystrophy","volume":"12","author":"JK Mah","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"pone.0232870.ref005","article-title":"A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy","author":"RG Victor","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"pone.0232870.ref006","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"K Bushby","year":"2014","journal-title":"Muscle Nerve"},{"issue":"10101","key":"pone.0232870.ref007","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"CM McDonald","year":"2017","journal-title":"The Lancet"},{"issue":"10","key":"pone.0232870.ref008","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(14)70195-4","article-title":"Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study","volume":"13","author":"T Voit","year":"2014","journal-title":"Lancet Neurol"},{"key":"pone.0232870.ref009","article-title":"A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy","author":"N Goemans","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"pone.0232870.ref010","author":"PTC Therapeutics","year":"2014","journal-title":"PTC Therapeutics Receives Conditional Approval in the European Union for Translarna\u2122 For the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy"},{"key":"pone.0232870.ref011","author":"US Food & Drug Administration","year":"2016","journal-title":"FDA grants accelerated approval to first drug for Duchenne muscular dystrophy"},{"issue":"10","key":"pone.0232870.ref012","doi-asserted-by":"crossref","first-page":"e0164684","DOI":"10.1371\/journal.pone.0164684","article-title":"Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy","volume":"11","author":"N Goemans","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0232870.ref013","doi-asserted-by":"crossref","first-page":"e0151445","DOI":"10.1371\/journal.pone.0151445","article-title":"Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study","volume":"11","author":"ES Mazzone","year":"2016","journal-title":"PLoS One"},{"key":"pone.0232870.ref014","doi-asserted-by":"crossref","unstructured":"Goemans N, Van den Hauwe M, Sajeev G, Yao Z, McDonnell E, Ward S, et al., editors. Validation of a prognostic score for changes in six-minute walk distance (6MWD) in patients with Duchenne muscular dystrophy (DMD). International Annual Congress of the World Muscle Society; 2017; St. Malo, France.","DOI":"10.1016\/j.nmd.2017.06.494"},{"issue":"15","key":"pone.0232870.ref015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.97.15.1453","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"97","author":"TR Pedersen","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"pone.0232870.ref016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ekir.2016.08.001","article-title":"Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial","volume":"1","author":"MV Irazabal","year":"2016","journal-title":"Kidney Int Rep"},{"issue":"18","key":"pone.0232870.ref017","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"B Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"pone.0232870.ref018","author":"U.S. Food and Drug Administration","year":"2019","journal-title":"Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products Guidance for Industry"},{"issue":"1","key":"pone.0232870.ref019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.23807","article-title":"The cooperative international neuromuscular research group Duchenne natural history study\u2014a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used","volume":"48","author":"CM McDonald","year":"2013","journal-title":"Muscle Nerve"},{"issue":"9","key":"pone.0232870.ref020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.nmd.2016.05.016","article-title":"Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy","volume":"26","author":"E Mercuri","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"pone.0232870.ref021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nmd.2016.11.013","article-title":"Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids","volume":"27","author":"N Goemans","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"pone.0232870.ref022","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","author":"CM McDonald","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"pone.0232870.ref023","first-page":"149","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"V Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"pone.0232870.ref024","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/dmcn.12213","article-title":"Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy","volume":"55","author":"A Mayhew","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"pone.0232870.ref025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1469-8749.2011.03939.x","article-title":"Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy","volume":"53","author":"A Mayhew","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"pone.0232870.ref026","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4155\/cli.11.113","article-title":"Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings","volume":"1","author":"K Bushby","year":"2011","journal-title":"Clin Investig (Lond)"},{"issue":"5","key":"pone.0232870.ref027","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mus.21212","article-title":"Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength","volume":"39","author":"AJ Skalsky","year":"2009","journal-title":"Muscle Nerve"},{"issue":"2","key":"pone.0232870.ref028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"K Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"pone.0232870.ref029","article-title":"Imperatives for DUCHENNE MD: a Simplified Guide to Comprehensive Care for Duchenne Muscular Dystrophy","volume":"7","author":"K Kinnett","year":"2015","journal-title":"PLoS Curr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T17:38:54Z","timestamp":1592501934000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232870"}},"subtitle":[],"editor":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232870","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}